Roberta Cirsmaru/LinkedIn
Jul 8, 2026, 05:53
Excellent PhD Defense by Roberta Cirsmaru on Gene Therapy for Hemophilia A – CRH French Reference Center for Hemophilia Lyon
CRH French Reference Center for Hemophilia Lyon shared a post on LinkedIn:
”Delighted to have served on the PhD defense committee of Roberta Cirsmaru, supervised by my friend Professor Follenzi.
Her thesis presented outstanding and innovative work in regenerative medicine, exploring the potential of ex vivo gene-modified BOECs for the treatment of hemophilia A.
Congratulations to Roberta on this excellent scientific achievement.
It was a pleasure to take part in such stimulating discussions on a field that continues to push the boundaries of translational medicine.”
Stay updated with Hemostasis Today.
-
Jul 13, 2026, 11:25Luisa Müller: Advancing Anticoagulation Strategies for VITT at ISTH 2026
-
Jul 13, 2026, 10:49Joshua Zeidner: Advancing Menin Inhibitor Therapy in MD Education AML-ALL US Focus 2026
-
Jul 13, 2026, 10:25Flora Peyvandi: A Practical Approach to ALT Elevation After Gene Therapy at ISTH 2026
-
Jul 13, 2026, 10:02Jessica Garcia: Where Science and Community Come Together at ISTH 2026
-
Jul 13, 2026, 09:46Fabrice Cognasse: Is There Such a Thing as the Perfect Platelet Product?
-
Jul 13, 2026, 09:42Cancer-Associated Arterial Thromboembolism: Redefining the Thrombotic Burden in Oncology
-
Jul 13, 2026, 05:59Connecting and Collaborating at ISTH 2026 – NNHF
-
Jul 13, 2026, 05:58Lara Monica: Back at ISTH – Looking Forward to Science and Reconnections!
-
Jul 13, 2026, 05:57Barbara Adams Krolak: Exciting Updates From the ISTH 2026 Regulatory Session